Selegiline Approved For Parkinson’s In Orally Disintegrating Tablet Form
This article was originally published in The Pink Sheet Daily
Executive Summary
Valeant’s Zelapar clears FDA after two “approvable” letters.
You may also be interested in...
Serono Adds Newron Parkinson's Disease Agent Safinamide With Licensing Deal
Phase III studies are investigating safinamide as an add-on therapy to dopamine agonists in early Parkinson's disease patients.
Serono Adds Newron Parkinson's Disease Agent Safinamide With Licensing Deal
Phase III studies are investigating safinamide as an add-on therapy to dopamine agonists in early Parkinson's disease patients.
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.